Back
Amicus Therapeutics Stock Price Chart
Alex Green's "Next Magnificent Seven" AI Stocks-Turn $7,000 into $1 Million!
Watch Alex's presentation and discover the AI stocks set to dominate!
Sell
45
FOLD
Amicus Therapeutics
Last Price:
10.71
Seasonality Move:
-8.45%
7 Day Trial
ALL ACCESS PASS
$
7
Invest in the Next Big AI Disruptor Today
Learn More- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing slight selling pressure.
Amicus Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.99 | Sell |
| 20-day SMA: | 11.25 | Sell |
| 50-day SMA: | 11.05 | Sell |
| 200-day SMA: | 11.43 | Sell |
| 8-day EMA: | 10.96 | Sell |
| 20-day EMA: | 11.13 | Sell |
| 50-day EMA: | 11.04 | Sell |
| 200-day EMA: | 11.14 | Sell |
Amicus Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 38.89 | Sell |
| Chaikin Money Flow: | -426216 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11 - 11.58) | Sell |
| Bollinger Bands (100): | (9.77 - 11.27) | Buy |
Amicus Therapeutics Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Amicus Therapeutics Stock
Is Amicus Therapeutics Stock a Buy?
- Amicus Therapeutics share price is 10.71 while FOLD 8-day simple moving average is 10.99, which is a Sell signal.
- The stock price of FOLD is 10.71 while Amicus Therapeutics 20-day SMA is 11.25, which makes it a Sell.
- Amicus Therapeutics 50-day simple moving average is 11.05 while FOLD share price is 10.71, making it a Sell technically.
- FOLD stock price is 10.71 and Amicus Therapeutics 200-day simple moving average is 11.43, creating a Sell signal.
FOLD Technical Analysis vs Fundamental Analysis
Sell
45
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy or a Sell?
-
Amicus Therapeutics stock is rated a Sell
The current Amicus Therapeutics [FOLD] share price is $10.71. The Score for FOLD is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Amicus Therapeutics Stock Info
Market Cap:
3.18B
Price in USD:
10.71
Share Volume:
1.67M
Amicus Therapeutics 52-Week Range
52-Week High:
14.57
52-Week Low:
9.02
Sell
45
Amicus Therapeutics (FOLD)
is a Sell
Amicus Therapeutics Share Price Forecast
-
What is the Amicus Therapeutics stock price today?
The Amicus Therapeutics stock price is 10.71 USD today. -
Will FOLD stock go up or go down?
Amicus Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Amicus Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amicus Therapeutics is overvalued.
Is Amicus Therapeutics Stock a Buy?
- Amicus Therapeutics share price is 10.71 while FOLD 8-day exponential moving average is 10.96, which is a Sell signal.
- The stock price of FOLD is 10.71 while Amicus Therapeutics 20-day EMA is 11.13, which makes it a Sell.
- Amicus Therapeutics 50-day exponential moving average is 11.04 while FOLD share price is 10.71, making it a Sell technically.
- FOLD stock price is 10.71 and Amicus Therapeutics 200-day simple moving average is 11.14, creating a Sell signal.
Fundamental Analysis of Amicus Therapeutics
Is Amicus Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.06 per share, an increase this year of $0.51 per share, and an increase next year of $0.29 per share.
Technical Analysis of Amicus Therapeutics
Should I short Amicus Therapeutics stock?
- FOLD Moving Average Covergence Divergence (MACD) indicator is -0.1, suggesting Amicus Therapeutics is a Sell
- Amicus Therapeutics Relative Strength Index (RSI) is 38.89, which suggest Amicus Therapeutics is oversold
- The Bollinger Bands (25) for Amicus Therapeutics is (11 - 11.58), which suggest Amicus Therapeutics is a Buy
- The Bollinger Bands (100) for Amicus Therapeutics is (9.77 - 11.27), which suggest Amicus Therapeutics is a Buy
* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.